Apimeds Pharmaceuticals US, Inc. (APUS) reporting calendar
Apimeds Pharmaceuticals US, Inc. files periodic reports with the SEC as APUS on NYSE. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 13 Jul 2026 – 1 Oct 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 26 May 2026
- Reports on record
- 6
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 53 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open APUS market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 26 May 2026 | 56 days | 0001213900-26-061013 |
| 10-K | 31 Dec 2025 | 4 May 2026 | 124 days | 0001213900-26-051139 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001213900-25-109280 |
| 10-Q | 30 Jun 2025 | 19 Aug 2025 | 50 days | 0001213900-25-078507 |
| 10-Q | 31 Mar 2025 | 20 May 2025 | 50 days | 0001213900-25-045588 |
| 10-K | 31 Dec 2024 | 15 Apr 2025 | 105 days | 0001213900-25-032206 |
Source: SEC EDGAR company submissions for CIK 0001894525. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.